IMMUNOe International Research Centers

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease1 trial
• Atopic dermatitis (eczema)1 trial

Phase

• Phase 32 trials

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Biogen1 trial
• Eli Lilly and Company1 trial

Closed trials

• Completed

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· Phase 3· Eli Lilly and Company· Source

• Terminated

  A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

  NCT04241068· Phase 3· Biogen· Source